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INTRODUCTION 
Hepatic disease is known to alter plasma lipids and lipoproteins (1,2). 
In 1851, Addison and Gull described xanthelasma and xanthomata in association 
with liver disease (3). Shortly thereafter, Austin Flint reported "Choles- 
teremia" in obstructive jaundice and suggested impairment of hepatic excretory 
function as a possible mechanism (4). More recently, abnormal lipoprotein 
forms have been described in association with lipid variations in hepatic 
disease (2,5). 
Striking increases in plasma cholesterol and phospholipids are found 
in biliary cirrhosis and extra-hepatic obstruction, and occasionally in 
acute hepatitis (1,6,7). The increase in serum cholesterol is uniquely dis¬ 
tinguished by a gross increase in free or unesterified cholesterol (8,9), 
while esterified cholesterol remains normal or only slightly elevated. In¬ 
creases in plasma phospholipids are proportionately greater than those in 
cholesterol and appear largely attributable to marked increases in lecithin 
(1,10,11). Triglycerides, in contrast, are normal or only slightly increased 
and the plasma, although icteric, is usually clear (9,12). Xanthomata and 
xanthelasma appear when the total lipid elevation is extreme and prolonged, 
and their disappearance is coincident with decreasing lipid concentrations 
(9). 
Plasma cholesterol in portal cirrhosis and most cases of acute hepatitis 
is either normal or slightly reduced (6,7). Although total cholesterol is 
normal, an increase in the ratio of free/esterified cholesterol, similar 
to that in biliary obstruction, is found in the early stages of acute hep¬ 
atitis (2). In patients in whom chronic liver disease develops as a result 
of viral hepatitis the ratio of free/esterified cholesterol returns to normal 
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during convalescence from the acute phase (13). Plasma phospholipids and 
triglycerides may be elevated during the acute phase of hepatitis with re¬ 
turn to normal values during convalescence (2,12,14), whereas in portal 
cirrhosis they are characteristically normal (2,12). 
Abnormal plasma lipoproteins have been described in hepatic disorders 
(2,5), however, their relationship to the normally circulating plasma lipo¬ 
proteins is not clear. Their presence appears dependent upon the degree and 
extent of biliary obstruction (2). Normally, the plasma lipoproteins and 
particles fall into four major groups. As defined by paper electrophoresis 
these are the beta, alpha, and prebeta lipoproteins, and chylomicrons (15, 
16). On ultracentrifugation the glyceride-rich prebeta lipoproteins and chylomi¬ 
crons are found at "very low" densities (<1.006, S^>20), whereas beta lipo¬ 
proteins are of "low" density (1.006 to 1.063, Sf 0-20) and alpha lipoproteins 
considered "high" density (1.063 to 1.21). Cohn fractionation (17) further dis¬ 
tinguishes alpha lipoproteins (fraction IV) from beta lipoproteins (fraction 
III). This normal plasma lipoprotein pattern is altered in biliary cirrhosis, 
some cases of extra-hepatic obstruction, and occasionally acute hepatitis. Alpha 
lipoproteins are either absent or reduced on ultracentrifugal (2,18,19) or elec¬ 
trophoretic analyses (2,20), and only a small amount of the lipoproteins present 
in the beta fraction on electrophoresis (2,21), or ultracentrifugation (2,22-24) 
is identifiable as beta immunochemically. Associated with this apparent reduc¬ 
tion of normal plasma lipoproteins is the appearance of abnormal lipoprotein 
forms. As much as 70 per cent of the plasma lipids may be found in Cohn frac¬ 
tion IV (normally contains alpha lipoproteins), however, these lipids are com¬ 
bined with protein at unusually high protein to lipid ratios and, although not 
precipitated by antisera to beta lipoprotein, are found to have beta mobility 
on electrophoresis and can be isolated with beta lipoproteins between densities 
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1.006 and 1.063 on preparative ultracentrifugation. In addition, most of the 
lipoproteins found in Cohn Fraction III (normally contains beta lipoproteins) 
have an increased lipid protein ratio, and though found with the beta lipo¬ 
protein fraction on electrophoresis and preparative ultracentrifugation 
(densities 1.006 to 1.063), are not precipitated by antisera specific for 
beta lipoprotein (2,5). 
The nature of these abnormal plasma lipoproteins has been a matter of 
considerable debate. Russ, Raymunt, and Barr (5) characterized three sep¬ 
arate abnormal beta lipoproteins on the basis of density gradient analyses, pro¬ 
tein/lipid ratios, and Cohn fractionation, and suggested that in obstructive 
jaundice most of the lipids are combined atypically with beta globulins. Kun- 
kel and Ahrens (21) studied sera from eight patients with biliary cirrhosis 
electrophoretically, and found increases in the beta globulin fraction to 
be directly related to the total lipid concentration. 
DeLalla et al. (25), using antisera prepared in rabbits against human 
alpha lipoproteins, found evidence for the existence of alpha lipoproteins 
of density less than 1.063 in the plasma of a patient with biliary cirrhosis. 
Furman et al. (18), suggested that the abnormal lipoproteins result from 
an atypical combination of plasma alpha and beta lipoproteins. When plasma 
samples from patients with biliary obstruction were subjected to in. vitro sonic 
oscillation, a marked increase in the plasma lipoprotein fraction of density 
greater than 1.063 was observed. On the basis of this and an earlier study 
in which they found plasma alpha lipoprotein concentration to vary with 
cholesterol ester concentration, the same authors suggested that a shift 
in the densities of the plasma alpha lipoproteins occurred with the increasing 
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lipid concentrations in biliary obstruction. 
Recently, Lemaire et al. (16,21), found that the phospholipids in sera 
from patients with obstructive jaundice are trichlorethylene extractable, where¬ 
as in subjects with either non-icteric sera or hepatocellular disease, the 
phospholipids are not trichlorethylene extractable. In those patients with 
obstructive jaundice, plasma alpha lipoproteins were absent on paper electro¬ 
phoresis, however, the abnormal readily extractable lipoproteins were found to 
have an antigenic specificity "close to that" of plasma alpha lipoproteins. 
The normal plasma lipoprotein pattern may also be altered by hepatocell¬ 
ular disease, here however, no abnormal lipoprotein forms have been described 
(2). Pierce and Gofman (24) reported elevations in the Sf 10-20 lipo¬ 
protein class in portal cirrhosis, and elevations in the Sf 0-100 lipoprotein 
class in acute hepatitis. Plasma alpha lipoprotein concentrations were re¬ 
duced on Cohn fractionation in patients with acute hepatitis (2). 
Recently, Fredrickson and Levy have demonstrated the value of immuno- 
electrophoretic methods in the identification and classification of plasma 
lipoproteins (28). These techniques permit characterization of the lipopro¬ 
teins based on their highly specific peptide moieties. The study of lipo¬ 
protein alterations in liver disease has been complicated by disturbances in 
lipid metabolism which could easily alter the physical and chemical properties 
of the lipoproteins without changing their antigenicity, a function of the 
peptide moiety. Current understanding of the nature and function of the 
plasma lipoproteins requires that classification of a lipoprotein as 
either normal or abnormal must in part be based on proper antigenic classifi¬ 
cation of its peptide moiety. 
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It is the purpose of the present study to combine the techniques 
of ultracentrifugation and electrophoresis with those of immuno- 
electrophoresis and immunochemical precipitation in order to: 
1. Better characterize the alterations in plasma lipoproteins 
associated with impairment of hepatic histology and function. 
2. Identify the nature of abnormal plasma lipoproteins described 
in biliary obstruction. 
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MATERIALS AND METHODS 
Subj ects. Fifty patients with suspected liver disease were studied 
using the combined facilities of the Yale-New Haven Medical Center and 
the National Heart Institute. Fasting plasma samples were obtained and 
the resulting lipoprotein profiles compared with alterations in hepatic 
function and histology. Several patients with acute disease were followed 
serially during the course of their hospitalization, others with chronic 
disease were evaluated at intervals of up to eight months. Those patients 
with concomitant thyroid disease, diabetes mellitus, pancreatitis, or other 
conditions known to alter plasma lipids were excluded from the study. The 
patients were classified as follows: 
Acute hepatitis 17 
Portal cirrhosis 13 
Post-necrotic cirrhosis 3 
Biliary obstruction 4 
Biliary cirrhosis 11 
primary 5 
secondary 6 
Normal liver  2 
Total 50 
In the seventeen patients with acute hepatitis (Table II) the diagnosis 
was based on the clinical picture and the biopsy findings. In fifteen patients 
these findings were most consistent with acute viral hepatitis, whereas in 
two, E.G. and R.B. there was a question of hepatocellular hepatitis secon¬ 
dary to drug hypersensitivity; cyclophosphamide (cytoxan) in the former, and 
halothane in the latter. The date of onset was arbitrarily defined as the day 
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on which jaundice or dark urine was first noted; this, however, was subject 
to certain inaccuracies since in many, vague symptoms of nausea, anorexia, 
or abdominal pain preceded the onset of icterus. All were jaundiced and 
had elevated serum glutamic oxaloacetic transaminase (SGOT) levels at the 
time of initial sampling. Four were followed serially during convalescence. 
One patient, E.B., developed acute hepatic necrosis and expired following 
unsuccessful attempts at exchange transfusions, however, the remainder sur¬ 
vived with return of liver function values to normal. 
In the thirteen patients with portal (Laennec's) cirrhosis (Table III), 
the typical histological changes of portal cirrhosis were found on liver 
biopsy and all patients gave a history of heavy alcoholic intake for more 
than 10 years. Ten patients were jaundiced at the time of sampling, and 
all were admitted for treatment of progressive hepatic deterioration with 
peripheral edema, ascites, and decreased serum albumin. Two patients, F.H. 
and N.T., had acute alcoholic hepatitis (florid cirrhosis) superimposed on 
pre-existing portal cirrhosis and were evaluated at weekly intervals. 
Three patients with post-necrotic cirrhosis (Table IV) were studied. 
All were jaundiced and all were female, ranging in age from 38 (M.H.) to 
76 (D.D.). In addition, two patients with hepatomegaly (Table IV) but his¬ 
tologically normal liver biopsy and normal liver function tests were evaluated. 
Four patients with extra-hepatic biliary obstruction (Table IV) were 
studied. At the time of sampling, only one, J.C., was jaundiced with elevated 
serum alkaline phosphatase. One patient, M.H., was found on biopsy to have 
acute and chronic pericholangitis (etiology undetermined), while J.C., F.M. , 
and D.G. later underwent cholecystectomy for choledocholithiasis and cholecysti¬ 
tis. All had histories of intermittent abdominal pain, pale stools and jaundice. 
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The diagnosis of biliary cirrhosis was made both on the basis of the 
liver biopsy and the clinical picture. The five with primary biliary 
cirrhosis (Table V-A) had histologically typical biopsies with exploratory 
laparotomies and operative cholangiograms that failed to reveal extra-hepatic 
sites of obstruction. All had hepatomegaly, hyperpigmentation, and a history 
of the insidious onset of jaundice with pruritis, darkening of the urine, and 
pale stools in the absence of abdominal pain, and chills and fever. Xanthelasma 
were present in all; R.I. and A.B. had tuberous and planar xanthomas, while 
C.D., M.D., and F.N. had a previous history of xanthomas. Ages ranged from 
42 (F.N.) to 54 (C.D.) and all were female. 
In the six patients with secondary biliary cirrhosis (Table V-B), four 
(T. L. , J.C., T.W. , and VI.C.) had partial biliary atresia, W.W. had a history 
of neonatal hepatitis with biopsy proven biliary cirrhosis at age 2, and M.J. 
had chlorpromazine hydrochloride (Thorazine) induced cholestatic hepatitis 
documented by biopsy, with progression toward biliary cirrhosis. All had 
xanthelasma and, tuberous and planar xanthomas at the time of sampling 
with the exception of T.W. who was in a terminal state and expired within 
4 weeks. 
Sample Collection. Fasting blood samples were obtained from each patient 
following at 12-14 hour overnight fasting period. Samples were collected in 
ethylene-diaminotetra-acetic acid (EDTA), 1 mg/ml, and cooled to 2-4°C with 
subsequent separation of the plasma in a refrigerated centrifuge (2-4°C) at 
2500 RPM. The supernatant plasma was refrigerated at 4°C until further tests 
were performed. Each sample was evaluated by means of paper electrophoresis, 
immunoelectrophoresis, and quantitative lipid analyses. 
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Paper Electrophoresis. Plasma lipoproteins were separated on paper 
electrophoresis by use of the modified Durrum hanging-strip method in bar¬ 
bital buffer of ionic strength 0.1, pH 8.6, containing 0.001 M EDTA and 
one per cent albumin (15). Electrophoresis was performed at room tempera¬ 
ture for a 16 hour period at 120 volts and a current of 0.75 to 1.0 ma 
per strip using Whatman No. 1 paper. Following electrophoresis the strips 
were dried at 95°C for 20 minutes, then stained by immersion in a super¬ 
saturated alcoholic solution of Oil-red-O for 4-6 hours at 40°C, and finally 
rinsed with water and dried (16). 
Precipitation. All the low density and very low density lipoproteins 
were separated from the plasma by polyanionic precipitation using heparin 
and manganese chloride in the cold. In this manner, alpha, or "high" density 
lipoproteins were isolated in supernatant, their cholesterol content being 
equivalent to that in the fraction of density greater than 1.063 isolated by 
preparative ultracentrifugation (29). Precipitation was accomplished by 
adding 0.15 ml 1.0 M manganese chloride and 6 mgm sodium heparin to 3 ml 
aliquots of plasma. The precipitate was allowed to develop for 15 minutes 
at 4°C and, following a 15 minute centrifugation at 4°C and 2,000 RPM, the 
supernatant was extracted. 
Ultracentrifugation. Preparative ultracentrifugation was used to isolate 
the plasma lipoproteins employing the methods and salt solutions first described 
by Havel et al. (30). 5 ml aliquots of plasma were ultracentrifuged at their 
own density (D=1.006) for 16 hours at 100,000 x g in the 40.3 rotor using the 
Spinco model L ultracentrifuge. The infranatant containing the fraction of 
density greater than 1.006 was then separated from the supernatant fraction 
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of density less than 1.006, using a lusteroid tube slicer and returned to 
a volume of 5 ml by the addition of 0.15 M-saline solution. The plasma 
fractions of density greater and less than 1.006 thus separated in the 
ultracentrifuge were then subjected to paper electrophoresis, and the 
mobility of their lipoprotein bands compared with each other and that of 
the lipoproteins in the whole plasma. 
In several patients the plasma fraction of density greater than 1.006 
was further separated in the ultracentrifuge into fractions of density 
greater than 1.063, and less than 1.063. This procedure provides a useful 
method for separating the normally occuring alpha and beta lipoproteins 
since the beta fraction is normally found in the density range 1.006 to 
1.063, while the alpha fraction occurs in the density range 1.063 to 1.21. 
The density of the plasma was adjusted to 1.063 by the addition of KBr and 
NaCl. Ultracentrifugation was carried out in the 40.3 rotor for 16 hours at 
2-4°C. The tubes were sliced and the density fractions further concentrated 
and purified by additional 16 hr periods of ultracentrifugation at 2-4°C using 
the 40.3 rotor. All fractions were then dialyzed at 4°C against 40 vol or 
more of 0.15 M NaCl containing 0.01 M EDTA at pH 6.5 to 7.3, the dialysis 
fluid being changed three times during a 24-hour period (29). 
Lipid Analysis. Quantitative cholesterol determinations were performed 
on the plasma, the plasma fraction of density greater than 1.006, and the 
supernatant of the heparin-manganese chloride precipitation using the 
Technicon Autoanalyzer method (31). Plasma beta-lipoprotein cholesterol 
was expressed as the difference between the fraction of density greater 
than 1.006 and the supernatant of the heparin-manganese chloride precipitation 
(16). The plasma cholesterol less the cholesterol in density fraction 
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greater than 1.006 gave the normally occuring pre-beta and/or chylomicron 
cholesterol (16). Plasma glycerides were determined by use of the Technicon 
autoanalyzer method. Plasma phospholipids were determined, using the method 
of Stewart and Hendry (32). 
Immunoelectrophoresis. Plasma immunoelectrophoresis was performed on 
each sample using both 1% agarose and 2% Noble agar employing the techniques 
of Grabar and Williams as modified for microscope slides by Scheidegger. The 
mobility of the lipoproteins is different on agar and agarose. In the agarose 
which is sulfate-free agar, beta lipoproteins move away from the origin 
assuming the mobility of beta-globulin and are more easily distinguished 
from prebeta and alpha lipoproteins. Immunoelectrophoresis was accomplished 
in 0.05 M barbital buffer at pH 8.2 using constant current (58 ma, agar, or 
44 ma, agarose) for 40 minutes (33). Antisera (50 to 60 pi) was then 
added to each trough and diffusion allowed to occur at room temperature 
(24-72 hours) in a high humidity chamber following which the slides were photo¬ 
graphed, washed overnight with saline, then distilled water, and finally 
stained with Oil-red-O in 60% ethanol for 12 hours at 40°C. Several double 
diffusion studies in agar on ouchterlomy plates with absorption of antigens 
by specific antibodies were performed using standard techniques. The antisera 
were prepared and characterized as previously described by Levy and Fredrickson 
(29)- Each sample was evaluated against anti-whole sera and, combined anti¬ 
alpha and beta lipoprotein sera (29)* In addition, several samples were 
evaluated with specific anti-alpha, or anti-beta lipoprotein sera when 
indicated. 
Delipidation Studies. Although ethanol-ether is known to precipitate 
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irreversibly the polypeptide of beta lipoprotein, it provides a relatively 
complete delipidation of alpha lipoprotein. In several patients this proce¬ 
dure was employed to further characterize lipoproteins which behaved immuno- 
chemically as alpha but presented with otherwise atypical properties. Plasma 
was injected through a no. 25 needle into 50 vol of ethano1:ether (3:2, vol: 
vol), and the mixture was left standing at 4°C for 18 to 24 hours. Follow¬ 
ing centrifugation at 4°C for 50-60 minutes, the precipitate was collected, 
washed once in ether, and dissolved in 1 ml of 0.9% NaCl (pH 7) containing 
0.001 M EDTA. The samples were then subjected to a variety of immunochemical 
and electrophoretic studies. 
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RESULTS 
The Tables and Figures referred to in the following section are found 
in the Appendix. For purposes of comparison, the normal values for plasma 
lipid and lipoprotein concentrations are listed with normal liver function 
values in Table 1. The normal pattern on paper electrophoresis is demon¬ 
strated in Figure 9. The normal plasma immunoelectrophoretic pattern on 
agarose using combined anti-alpha and beta lipoprotein sera (29) is demon¬ 
strated in Figure 4. Using the same antisera, immunoelectrophoresis of 
normal plasma on agar results in a pattern similar to that of M.J. on 
12/12/66, Figure 10, with the exception that the alpha band is less in¬ 
tense. 
Acute Hepatitis. Lipids. The results of the plasma lipid determina¬ 
tions in seventeen patients with acute hepatitis are listed with their corres¬ 
ponding liver function values in Table II. Total cholesterol concentrations 
varied, being normal in eleven, depressed in four (E.B., R.B., M.W., and S.K), 
and elevated in two (A.R., and 0.C). Plasma triglycerides were elevated in 
thirteen of seventeen, but only rarely to values over 250 mgm70. 
Lipoproteins. Striking depressions of alpha lipoprotein concentration 
determined by heparin-manganese chloride precipitation were found in sixteen 
of the seventeen patients, and in the remainder, E.D., the value was in 
the lower range of normal. Alpha lipoproteins were also depressed or absent 
on paper electrophoresis and immunoelectrophoresis. In four subjects followed 
serially the depression of alpha lipoprotein concentration was reversible, 
returning to normal as liver function improved. This serial increase in 
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alpha lipoprotein values with recovery could be demonstrated by ultra¬ 
centrifugation and precipitation as well as by paper electrophoresis 
(Figure 1) or immunoelectrophoresis (Figure 2). It should be noted in 
Figure 1 that the increasing alpha lipoprotein concentration, associated 
with improvement of liver function, was also accompanied by a return of 
lipid staining material in the prebeta region. 
In contrast, beta lipoprotein concentrations were normal in sixteen of 
the seventeen. Only in 0.C., where the total cholesterol was elevated to 
565 mgm%, was the beta lipoprotein fraction elevated, this occurred in the 
presence of markedly depressed alpha lipoprotein concentrations. In those 
patients with elevated triglycerides and depressed alpha lipoprotein levels, 
material with beta mobility was atypically present at density less than 
1.006 (Figure 3). With improvement of liver function and return of alpha 
lipoprotein concentrations to normal, lipid staining material in beta pos¬ 
ition could be found only in the density range 1.006 - 1.063 (normal beta 
lipoprotein density range) and the pre-beta band reappeared (Figure 1). 
In the present study, no specific correlation was demonstrated between 
given liver function values and alpha lipoprotein concentration. However, 
in the four patients followed serially, improvement in liver function was 
associated with a return to normal alpha lipoprotein concentrations. 
Portal Cirrhosis. Lipids. Plasma lipid and liver function values in 
thirteen with portal cirrhosis are listed in Table III. Total cholesterol 
varied, being normal in five, depressed in seven, and elevated in one. Plasma 
triglycerides were normal in nine and slightly elevated in four. 
Lipoproteins. Moderate to severe decreases in alpha lipoprotein con¬ 
centration were found in eleven of thirteen patients, the remainder, J.M. 
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and M.D., had values in the lower range of normal. As in acute hepatitis, 
alpha lipoproteins were depressed on paper electrophoresis, albeit not as severe, 
and similar changes were observed on immunoelectrophoresis. In two, F.H. 
and N.T., with acute hepatocellular disease superimposed on long standing 
cirrhosis there was a severe depression of alpha lipoproteins (Figure 4), simi¬ 
lar to those seen in acute hepatitis. Beta lipoprotein concentrations were 
normal in ten of thirteen, being slightly depressed in two, F.J., and P.O., 
and elevated in one, M.D. 
Post-necrotic Cirrhosis. The plasma lipids and liver function values 
in three patients with post-necrotic cirrhosis are given in Table IV. In 
all, the total cholesterol was decreased. All had decreased alpha lipoprotein 
concentrations by heparin-manganese chloride precipitation and by immuno¬ 
electrophoresis and paper electrophoresis. The beta lipoprotein concentra¬ 
tions were low normal. 
Extra-hepatic Obstruction. The plasma lipids and liver function values 
in four patients with extra-hepatic obstruction are given in Table IV. Only 
one, J.C., had abnormal liver function values when sampled. None had elevated 
total cholesterols and the alpha lipoprotein concentrations were all within 
normal limits. 
Normal liver biopsy. The plasma lipids and liver function values for 
two patients with normal liver biopsies are given in Table IV. Both were 
evaluated because of hepatomegaly, however, both had normal plasma lipid and 
liver function values. Normal patterns were present on paper electrophoresis 
and immunoelectrophoresis. 
Biliary Cirrhosis. Lipids. Plasma lipids and liver function values 
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in eleven patients with biliary cirrhosis are presented in Table V. The 
patients have been divided into those with primary and those with secondary 
biliary cirrhosis, and listed in order based on the duration of disease. 
Total cholesterol varied in the eleven patients from 134 to 2,056 mgm7o, 
being highest in those patients (M.J., and R.I.) whose disease was of the 
shortest duration. In seven patients of twelve, total cholesterols were 
elevated. In five on whom plasma phospholipids were determined, all were 
elevated, with decreases in the cholesterol-phospholipid ratio. In the en¬ 
tire group with biliary cirrhosis, the plasma triglycerides were normal 
or only slightly elevated and quite typically did not parallel the striking 
increases in cholesterol and phospholipids. 
Lipoproteins. Unusual changes in alpha lipoprotein properties and 
concentrations were observed which varied with the degree of parenchymal 
damage and change in total lipids. 
In five patients with late stage biliary cirrhosis and marked parenchymal 
destruction, the alpha lipoprotein concentrations were reduced as in hepatocell¬ 
ular disease. In one patient, F.N., alpha lipoprotein concentrations were 
observed to decrease in association with deterioration of the clinical picture 
and the appearance of Mallory bodies with continued parenchymal destruction on 
biopsy. 
By contrast, in all seven patients with biliary obstruction and little 
or no evidence of parenchymal damage, the alpha lipoproteins were increased 
and showed unusual physical properties. 
In five patients with moderately elevated cholesterols, (W.W., W.C., J.C., 
T.L., and M.J., 12-66) alpha lipoprotein concentration was increased, and a 
broad band of lipid staining material was found in the alpha position 
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on paper electrophoresis (Figure 5). Following ultracentrifugation, the 
lipid staining material with alpha lipoprotein mobility was present atypi- 
cally at a density less than 1.063 (normally contains only beta-lipoprotein) 
as demonstrated both by paper electrophoresis (Figure 5) and immunoelectro- 
phoresis (Figure 6). After precipitation of plasma with heparin-manganese 
chloride, the supernatant contained only material of alpha lipoprotein 
mobility. Following ultracentrifugation, substantial amounts of this mat¬ 
erial were found in the fraction of density less than 1.063 (Figure 7). 
The presence of material at a density less than 1.063 with alpha lipo¬ 
protein mobility on paper electrophoresis and immunoelectrophoresis was 
similarly demonstrated in the plasma supernatant following precipitation with 
specific anti-beta lipoprotein sera. 
These results on immunoelectrophoresis and paper electrophoresis of 
the plasma fractions separated by ultracentrifugation and chemical precipi¬ 
tation, suggested the possibility of an abnormal lipoprotein form of beta 
lipoprotein density and alpha lipoprotein mobility. Isolated preparations 
of the abnormal lipoprotein fraction proved to have complete immunochemical 
identity with normal alpha lipoprotein. On immunodiffusion using agarose 
(Figure 8), the material with alpha lipoprotein mobility found at density 
less than 1.063, isolated in the supernatant either by heparin-manganese 
chloride precipitation or addition of specific anti-beta lipoprotein sera, 
proved to have complete immunochemical identity with alpha lipoprotein ob¬ 
tained from a normal subject. 
In two patients, R. I. and M.J., 9-66, with minimal parenchymal damage, 
total cholesterols exceeded 1,000 mgm%. Alpha lipoproteins were not detected 
by heparin-manganese chloride precipitation, however an unusual pattern was 
encountered on both paper and immunoelectrophoresis. On paper electrophoresis, 
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(Figure 9, M.M - 9/15/66) normal lipid staining material was present in 
the beta position, none appeared in the alpha position, and a peculiar, thin 
band of cathode-migrating, lipid staining material was present near the 
origin. Similarly, following immunoelectrophoresis on agar (Figure 10, 
M.J. - 9/15/66) using combined anti-alpha and beta lipoprotein sera, two 
immunochemically distinct lipoprotein fractions were identified, one in the 
normal beta position, the other encircling the well and migrating behind 
the lipoprotein fraction in beta position. On ultracentrifugation essentially 
all of the lipoproteins were isolated between density 1.006 and 1.063 (Figure 
11). 
Several procedures were undertaken to immunochemically define the two 
lipoprotein fractions, and representative patterns following immunoelec¬ 
trophoresis on agar are given in Figure 11. Agar was used for immunoelec¬ 
trophoresis rather than agarose, since it provided better separation of the 
two lipoprotein fractions. The lipoprotein fraction migrating in beta position 
was not present (Figure 11, plate A) when: (1) the plasma was precipitated 
with anti-beta lipoprotein sera before immunoelectrophoresis, (2) the combined 
anti-alpha and beta lipoprotein sera was absorbed with beta lipoprotein, or 
(3) specific anti-alpha lipoprotein sera was used in immunoelectrophoresis 
rather than the combined anti-alpha and beta lipoprotein sera. Similarly, the 
lipoprotein fraction encircling the well and migrating behine the lipoprotein 
fraction in beta position was not present (Figure 11, plate B) when (1) the 
plasma was precipitated with anti-alpha lipoprotein sera before immunoelectropho 
resis, (2) the combined anti-alpha and beta lipoprotein sera was absorbed with 
alpha lipoprotein, or (3) specific anti-beta lipoprotein sera was used in immuno 
electrophoresis rather than the combined anti-alpha and beta lipoprotein sera. 
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When the atypical lipoprotein fraction migrating near the beta lipoprotein frac¬ 
tion was delipidated using ethanol-ether, the resulting peptide was found to 
have alpha mobility on immunoelectrophoresis using agarose, and reacted with 
specific anti-alpha lipoprotein sera (Figure 12, plate A), but not with 
specific anti-beta lipoprotein sera (Figure 12, plate B). 
The two lipoprotein fractions occurring at density less than 1.063 
with beta lipoprotein mobility on immunoelectrophoresis were thus defined 
immunochemically as beta and alpha lipoprotein, the latter assuming alpha 
mobility when delipidated. 
One patient, M.J., with cholestatic hepatitis was followed during a 
three month period as total cholesterol concentration fell from 2056 mgm% 
to 668 mgm%. Initially, when total cholesterol concentrations exceeded 
2056 mgm70, the electrophoretic mobility of alpha lipoprotein was altered 
as previously described (Figure 9, M.J., 9-15 and Figure 10, M.J., 9*15). 
However, as total cholesterol concentration decreased to 668 mgm70 alpha 
lipoproteins regained their normal mobility on paper electrophoresis (Figure 
9, M.J., 12-12), where they were present as a broad, intensely staining 
band. A similar return of alpha lipoproteins to normal position was observed 
on immunoelectrophoresis in agar (Figure 10, M.J., 12-12). As total 
cholesterol concentration decreased, alpha lipoprotein concentration remained 
elevated, and although alpha lipoproteins were present in the supernatant 
following heparin-manganese chloride precipitation, large percentages were 
found at densities less than 1.063. 

-20- 
DISCUSSION 
The present study demonstrates the alterations in normal plasma 
lipoprotein patterns which occur in liver disease. The patterns for 
hepatocellular disease and biliary obstruction are different. In hepato¬ 
cellular disease, plasma alpha lipoprotein concentration is reduced. 
In biliary obstruction unaccompanied by hepatocellular destruction, 
the concentration of plasma alpha lipoprotein is increased and its ultra¬ 
centrifugal and electrophoretic properties are altered. The previously 
described abnormal lipoproteins of biliary obstruction are seen to result 
from changes in the properties and concentration of normal alpha lipo¬ 
protein . 
The reduction of plasma alpha lipoproteins in acute hepatitis is 
striking, and the plasma lipoprotein patterns on immunoelectrophoresis 
and paper electrophoresis are difficult to distinguish from those of Tangier 
disease (16,34), in which plasma alpha lipoproteins are congenitally absent 
or severely deficient. In acute hepatitis, material with beta mobility 
is atypically present at densities less than 1.006 when hyperglyceridemia 
accompanies the severely depressed alpha lipoprotein concentrations. Sim¬ 
ilar patterns are found in Tangier disease when hyperglyceridemia is in¬ 
duced with high carbohydrate diets (35). As alpha lipoprotein concentration 
returns to normal, the glycerides are once again transported in the prebeta 
fraction. No evidence was obtained in the present study to suggest that 
alpha lipoprotein deficiencies in hepatocellular disease are secondary to 
hyperglyceridemia. 
Deficiencies of plasma alpha lipoproteins in hepatocellular disease 
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have previously been reported by Pierce and Gofman (24), and later by 
Eder et al. (2) who observed reversible depression of plasma alpha lipo¬ 
proteins on Cohn Fractionation of patients followed serially with acute 
hepatitis. No specific correlation with liver function tests was noted 
by Eder et al., however, return to normal alpha lipoprotein patterns 
coincided with subsidence of icterus. Pierce et al. (22) have correlated 
the lipoprotein patterns in acute hepatitis with changes in the icterus 
index and total bilirubin concentrations. In the present study no specific 
correlations between plasma alpha lipoprotein concentrations and liver 
function tests were noted, however, in acute hepatitis, improvement in 
liver function values was associated with rising alpha lipoprotein con¬ 
centration. 
In biliary obstruction with hepatocellular damage, the alpha lipo¬ 
protein levels are low as in other forms of hepatocellular disease, and the 
lipids are transported by the beta lipoproteins. The reasons for decreased 
plasma alpha lipoprotein levels in hepatocellular disease are unestablished. 
The liver has been demonstrated as a site of lipoprotein synthesis in per¬ 
fused rat liver (36-38). However, extra-hepatic sites of lipoprotein synthesis 
have been demonstrated (39-40), and recent studies indicate lipoprotein synthe¬ 
sis continues following hepatectomy in the dog (41). Both plasma lipoproteins 
I O 1 
have a biological half-life of about four days as determined by I studies 
(42,43). Thus, from data currently available, there is no apparent explan¬ 
ation for the preferential effect of hepatocellular disease on plasma alpha 
lipoprotein concentration. 
This study demonstrates that increases in alpha lipoprotein concen- 

-22- 
tration result when biliary obstruction occurs with only minimal hepatocell¬ 
ular destruction. With increasing hyperlipidemia the electrophoretic and 
ultracentrifugal properties are remarkably altered resulting in the appearance 
of an abnormal lipoprotein. Lemaire et al. (26,27) have observed similar 
alterations in obstructive jaundice. They describe a lipoprotein form with 
antigenicity close to that of alpha and immunoelectrophoretic mobility and 
ultracentrifugal characteristics similar to that of the beta lipoproteins. 
The present study demonstrates the immunochemical identity of alpha lipo¬ 
proteins from normal plasma with the abnormal lipoproteins appearing at 
plasma densities less than 1.063 in obstructive jaundice. 
The effects of biliary obstruction on the plasma lipoprotein pattern 
are unusual. Considerable debate has surrounded the nature of the abnormal 
lipoproteins in this condition. Even though plasma lipoproteins may be 
characterized by a variety of methods which include electrophoresis, ultra¬ 
centrifugation, and chemical and immunochemical precipitation, none of 
these provides an absolute method of classification. This is demonstrated 
by the paradoxical nature of the abnormal lipoproteins previously described 
in obstructive jaundice (2,5) which behave as alpha lipoproteins on Cohn 
fractionation but resemble beta lipoproteins in their ulcentrifugal and 
electrophoretic patterns. 
Recently, Fredrickson and Levy (16,28,29) have stressed the value of 
immunoelectrophoresis in the characterization of plasma lipoproteins. The 
method permits identification of the lipoprotein apoproteins, the protein 
portion, as either alpha or beta, and is relatively specific for the peptide 
moiety, albeit ultracentrifugation, thawing, and storage at room temperature 
may slightly alter alpha lipoproteins (16) and minor genetic variations 
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in beta lipoproteins have been reported (28). Hence, the definition of 
lipoproteins as abnormal must appropriately include antigenic characteri¬ 
zation . 
The present study confirms the value of immunochemical techniques in 
the interpretation of plasma lipoprotein function and identity. In states 
of hyperphospholipidemia and hypercholesterolemia the density and electro¬ 
phoretic mobility of the plasma lipoproteins are altered without changing 
their antigenicity. In this situation, identification of the peptide moiety 
provides the clue to a more specific understanding of the altered plasma lipo¬ 
protein patterns. 
The mechanism by which alpha lipoproteins are altered in biliary ob¬ 
struction remains unestablished. Lemaire et al. (26,27) have recently shown 
that plasma phospholipids in obstructive jaundice are trichlorethylene 
extractable whereas in normals and those with hepatocellular disease this 
is not the case. Moreover, the phospholipids are only extracted from 
the "abnormal lipoproteins" in obstructive jaundice. They postulate a 
disruption of the normal protein phospholipid bond to occur in obstructive 
jaundice, which thereby alters the stability and properties of the lipo¬ 
protein. Lecithin and free cholesterol are known to be the major lipids 
present in bile (44), however, the mechanism of the hyperphospholipidemia 
and hypercholesterolemia in biliary obstruction is poorly understood. 
Retention of bile lipids does not appear to account entirely for the 
hyperlipidemia, since an increased rate of cholesterol synthesis is observed 
following bile duct ligation in the rat (45) and phospholipid synthesis is 
increased in patients with jaundice and hyperlipidemia (46). Byers et al. 
(47) have noted hypercholestermia occurring in rats eight hours following 
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intravenous lecithin infusion, however, increased labeled acetate 
uptake was not observed until 24 hours following the infusion. They con¬ 
clude that hyperphospholipidemia causes a shift in cholesterol from peripheral 
tissues to blood thereby altering the partition of cholesterol between 
liver and blood and indirectly resulting in net increase of cholesterol 
synthesis. The effects of hyperphospholipidemia on lipoprotein synthesis 
are unestablished. Similar alterations in the ultracentrifugal properties 
of alpha lipoprotein are reported in abeta lipoproteinemia (48). 
The metabolism and transport kinetics of plasma lipoproteins are not 
well understood. The present study demonstrates a pronounced effect of 
hepatocellular disease and biliary obstruction on plasma alpha lipoprotein 
concentration. These variations may prove of value diagnostically in the 
differentiation of obstructive and hepatocellular jaundice. Of theoretical 
as well as practical interest is the role of biliary obstruction and the 
associated hyperphospholipidemia and hypercholesterolemia in altering 
the properties and concentrations of plasma alpha lipoprotein. Future 
investigations in this field using this abnormal lipoprotein as a model 
will undoubtedly enable us to gain a more precise understanding of the 
relationship of lipid to protein in the complex lipoproteins. 
The demonstration of an acquired plasma lipoprotein deficiency in 
hepatocellular disease is noteworthy and emphasizes the essential role 
of the liver in the overall metabolism of plasma lipids and lipoproteins. 

-25- 
SUMMARY 
Lipoprotein profiles from fifty patients with liver disease were com¬ 
pared to alterations in hepatic function and histology. The effects of 
liver disease were reflected by either an increase or depression of 
plasma alpha lipoprotein concentration. Increases were accompanied by 
unusual changes in the properties of these lipoproteins. 
Alpha lipoproteins were absent on paper electrophoresis of plasma 
from two biliary cirrhotics (one primary) with minimal parenchymal damage 
and cholesterol > 1,000 mgY0, however, two immunochemically different 
Heparin-MnCl2 precipitable lipoproteins were found between densities 1.006 - 
1.063 which migrated slowly on agar and agarose. One lipoprotein was beta; 
the other reacted with anti-alpha lipoprotein sera and, when delipidated 
assumed alpha mobility. In five biliary cirrhotics with moderately elevated 
lipids, alpha lipoproteins were increased and again found between densities 
1.006-1.063, however, in these, the alpha lipoproteins formed a broad alpha 
migrating band on paper and agar electrophoresis. Five late stage biliary 
cirrhotics had markedly depressed alpha lipoprotein levels similar to those 
encountered in seventeen patients with acute hepatitis. In four of the latter 
followed serially, alpha lipoproteins returned to normal levels as hepatic 
function improved. In thirteen with Laennec's cirrhosis and three with post¬ 
necrotic cirrhosis alpha lipoproteins were depressed. 
It is suggested that biliary obstruction without hepatocellular destruction 
alters the properties of alpha lipoprotein. With hepatocellular destruction, 
alpha lipoprotein levels are decreased. These observations are of theoretical 
and diagnostic interest. 
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APPENDIX 

TABLE I 
Normal Values for plasma lipids and liver function tests. 
A. Plasma Lipids* 
Age 
Years 
Cholesterol 
Total Alpha 
Male Fema1e 
mg/100 ml. mg/100 ml. mg/100 ml. 
Beta Triglyceride 
mg/100 ml. mg/100 ml 
0-19 120-230 30-65 30-70 50-170 10-140 
20-29 120-240 35-70 30-75 60-170 10-140 
30-39 140-270 30-65 35-80 70-190 10-150 
40-49 150-310 30-65 40-85 80-190 10-160 
50-59 160-330 30-65 35-85 80-210 10-190 
B. Plasma Phospholipids** 
Age Phospholipids, mean 
Years and 90 per cent limits 
1-19 215(155-265) 
20-29 235(175-300) 
30-39 270(205-340) 
40-49 275(185-355) 
50-59 305(225-380) 
C. Normal liver function values 
Bilirubin. Total less than 1.30 mg/100 ml. 
Direct less than 0.30 mg/100 ml. 
Alkaline Phosphatase less than 8.6 Shinowara, J.R. et al. units 
Serum glutamic oxaloacetic transaminase (SGOT) 15-41 units 
* Based on 95 per cent fiducial limits calculated for small samples-all 
values rounded to nearest 5 mg. Taken from Fredrickson, Levy and Lees, 
New England J. Med, 1967, 276, 34. 
** From Stanbury, Wyngaarden and Fredrickson, The Metabolic Basis of Inherited 

TABLE II 
Plasma lipid and liver function values 
in seventeen patients with acute hepatitis* 
Cholesterol Bilirubin Aik. 
Subject Age Sex Day Total Alpha Beta Trig. PL Tot./Direct Phos. SGOT 
mg/100 ml • 
F.M. 43 M 16 150 5 117 239 336 20.0/12.0 7.2 906 
23 184 13 145 188 262 13.6/6.6 8.9 234 
30 186 29 117 182 248 5.2/2.7 6.3 112 
45 40 386 2.2/1.0 6.1 25 
H. R. 24 F 16 172 31 126 134 8.0/5.0 5.2 750 
23 182 42 134 77 226 5.1/3.2 5.3 122 
30 188 51 119 75 243 
R. L. 27 M 4 190 18 144 297 17.0/10.0 7.4 980 
11 174 27 133 134 
M. D. 59 F 21 282 28 182 273 298 3.4/1.6 9.7 119 
35 258 33 265 7.0 36 
E. B. 50 F 2 153 6 124 60 137 19.7/5.7 21.3 1296 
J.K. 20 M 9 174 6 142 174 4.1/2.0 5.6 112 
E.G. 59 M 31 228 10 162 296 8.0/4.0 5.5 51 
R. B. 57 F 44 114 6 104 166 157 70.0/38.0 16.8 365 
A. R. 23 M 14 271 28 177 8.0/5.0 14.9 238 
P. C. 18 M 22 132 16 84 163 6.2/3.1 12.5 572 
M.W. 62 F 12 112 6 100 32.0/15.0 17.1 237 
F.W. 49 M 28 220 9 187 3.0/2.1 3.8 64 
A. C. 40 M 28 230 16 178 298 4.0/2.0 24.5 480 
W.F. 18 M 16 194 19 155 174 6.0/3.0 14.1 301 
E. D. 20 M 17 178 36 124 100 2.0/1.0 8.4 153 
0. C. 64 F 19 565 15 325 534 15.0/6.0 15.0 310 
S.K. 22 M 6 110 3 75 224 2.0/1.0 3.2 430 
Abbreviations: Trig.= Triglyceride, PL= Phospholipid, Aik. Phos.= Alkaline 
Phosphatase, SGOT= Serum glutamic oxaloacetic transaminase. 

TABLE III 
Plasma lipid and liver function values 
in thirteen patients with portal cirrhosis* 
Subj ect Age Sex 
Cholesterol 
Total Alpha Beta 
mg/100 ml. 
Trig. PL 
Bi lirubin 
Tot./Dir. 
Aik. 
Phos. SGOT 
Proteins 
Alb./Glob. 
M. C. 64 F 166 17 121 150 1.6/0.7 2.2 35 3.0/3.2 
A. L. 39 M 160 16 102 160 199 0.8/0.4 5.6 45 2.1/4.8 
P.0. 68 M 104 27 67 20 113 2.0/0.8 7.5 57 1.8/4.0 
J.M. 46 M 162 36 110 34 6.0/3.5 3.8 107 1.7/6.3 
M. D. 49 F 350 32 290 166 293 3.0/1.0 7.2 59 3.4/3.3 
F.M. 52 M 102 4 86 85 21.0/16.0 8.6 255 2.6/5.1 
124 8 106 68 140 20.1/11.2 8.6 164 
142 10 126 29 9.0/4.5 5.9 144 2.6/5.5 
N.T. 51 M 128 3 102 200 214 35.1/25.2 19.3 425 2.2/4.2 
180 6 290 51.2/30.2 8.1 250 
184 8 138 133 250 14.1/8.0 6.3 168 2.3/3.7 
A. P. 67 F 146 24 98 117 177 1.1/0.3 6.5 43 2.6/5.1 
H.D. 44 F 122 15 95 98 9.1/5.7 7.7 82 2.7/3.5 
J. B. 27 F 198 30 128 294 7.6/4.2 7.7 88 2.4/5.9 
S. B. 70 F 110 5 105 89 16.2/8.1 16.7 147 2.3/4.7 
F. J. 47 M 84 16 62 50 0.7/0.1 9.8 32 2.6/3.9 
M. J. 51 F 178 17 133 128 1.5/0.7 16.8 44 2.6/4.4 
* Abbreviations: Trig.= Triglyceride, PL= Phospholipid, Aik. Phos.= Alkaline 
Phosphatase, SGOT= Serum glutamic oxaloacetic transaminase, Tot.= total, 
Dir.= direct, Alb.= Albumin, Glob.= globulin. 

TABLE IV 
Plasma lipid and liver function values in other patients studied* 
Subj ect age sex 
Cholesterol 
Total Alpha Beta 
mg/100 ml. 
Trig. PL 
Bilirubin 
Tot. / Dir. 
Aik. 
Phos. SGOT 
A. Post -necrotic cirrhosis 
R. S. 65 F 136 28 104 4.2/1.4 13 68 
D.D. 76 F 128 23 77 158 204 2.1/0.7 4 13 
M.H. 38 F 160 29 107 70 3.2/1.6 27 68 
B. Extra-hepatic obstruction 
J. C. 76 M 280 30 232 134 302 3.0/1.7 13 81 
F.M. 23 F 120 35 77 65 0.7/0.3 7 54 
D.G. 45 M 158 40 116 54 1.1/0.5 5 31 
M.H. 43 F 226 37 153 230 0.9/0.2 9 64 
C. Normal liver biopsy 
R.R. 71 F 170 34 124 81 0.4/0.1 4.7 11 
L. A. 65 F 198 45 125 136 0.7/0.1 3.4 11 
* Abbreviations: Trig.= Triglyceride, PL= Phospholipid, Aik. Phos.= 
Alkaline phosphatase, SGOT= Serum glutamic oxaloacetic transaminase, 
Tot.= Total, Dir.= Direct. 

TABLE V 
Plasma lipid and liver function values 
in eleven patients with biliary cirrhosis* 
Cholesterol Bilirubin Aik. 
Subj ect Age Sex Duration Date Total Alpha Beta Trig. PL Tot./Dir. Phos. SGOT 
years mg/100 ml. 
A. Primary biliary cirrhosis 
R. I. 45 F 2 8/66 965 N. P. § 908 408 8.5/4.5 44 176 
1/67 1140 N. P. § 1096 348 10.0/4.0 103 112 
C. D. 54 F 4 8/66 150 5 129 143 42.3/23.1 21 112 
10/66 238 7 231 126 24.0/12.4 21 85 
A. B. 51 F 5 1/66 452 10 406 282 809 20.1/12.3 63 114 
8/66 506 7 463 290 30.2/18.3 63 51 
M. D. 46 F 5 1/66 292 40 222 92 383 4.2/2.0 43 222 
F.N. 42 F 6 2/66 312 34 246 135 4.4/2.3 60 175 
8/66 404 13 373 190 7 58 13.2/6.1 38 195 
B. Secondary biliary cirrhosis 
M. J. 19 M 1/2 9/66 2056 N. P. 2000 221 22.0/13.4 235 195 
12/66 668 82 534 114 2.0/1.0 197 110 
T. L. 6 M 6 11/66 236 106 94 99 1.0/0.1 40 141 
J.C. 9 F 9 5/66 192 60 130 59 279 5.0/3.2 25 256 
w. c. 9 F 9 7/65 364 128 225 92 444 1.2/0.5 65 108 
w.w. 13 F 12 7/66 276 96 178 86 1.0/0.3 64 122 
T.W. 18 M 18 12/66 134 6 no 182 9.2/4.3 16 42 
* Abbreviations: Trig.= Triglyceride, PL= Phospholipid, Aik. Phos.= Alkaline phos¬ 
phatase, SGOT= Serum glutamic oxaloacetic transaminase, Tot.= Total, Dir.= Direct. 
§ N.P.= none present following precipitation with heparin-MnC^• 

FIGURE 1. 
SERIAL LIPOPROTEIN ELECTROPHORESIS ON PAPER OF PLASMA SAMPLES 
FROM PATIENT F.M. RECOVERING FROM ACUTE VIRAL HEPATITIS. 
The alpha and prebeta lipoprotein bands are seen to return 
with improving liver function values. The proteins are 
stained for lipid with oil red 0 after electrophoresis. 
All paper strips subsequently shown stained with oil red 0. 
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FIGURE 2. 
SERIAL IMMUNOELECTROPHORESIS ON AGAROSE OF PLASMA FROM 
PATIENT F.M. RECOVERING FROM ACUTE VIRAL HEPATITIS. 
The troughs contain combined anti-alpha and beta 
lipoprotein sera R^A (48). All visible precipi¬ 
tation lines were shown to stain for lipid. 
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FIGURE 3. 
PAPER ELECTROPHORESIS OF PLASMA FROM A PATIENT WITH ACUTE 
VIRAL HEPATITIS AND ELEVATED PLASMA TRIGLYCERIDES. 
Lipid staining material is atypically present in the 
beta position at D< 1.006. The alpha lipoprotein 
concentration is severely depressed and no alpha lipo¬ 
protein band is present on paper electrophoresis. With 
return of alpha lipoprotein concentrations to normal, 
the lipid staining material at D< 1.006 was found 
in the normal prebeta position. 


7 
FIGURE 4. 
IMMUNOELECTROPHORESIS ON AGAROSE OF PLASMA FROM A NORMAL PATIENT 
AND TWO PATIENTS F.H. AND N.T., WITH SEVERE HEPATOCELLULAR DISEASE. 
The troughs contain anti-alpha and beta lipoprotein sera, R^A 
(48). Alpha lipoproteins are severely depressed in N.T. and 
F.H. All precipitation lines subsequently stained for lipid. 
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FIGURE 5. 
PAPER ELECTROPHORESIS OF PLASMA FROM PATIENT W.W. WITH BILIARY CIRRHOSIS. 
The plasma, lipoprotein fraction of density > 1.063 (1.063 B) and 
lipoprotein fraction of density < 1.063 (1.063 T) have been subjected 
to paper electrophoresis. A broad lipid-staining band with alpha 
mobility is present in the plasma and fractions 1.063 T and 1.063 B. 
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FIGURE 6. 
IMMUNOELECTROPHORESIS ON AGAROSE OF PIASMA FROM PATIENT W.C. WITH BILIARY CIRRHOSIS. 
All troughs contain combined anti-alpha and beta lipoprotein sera, R^A (48). 
Material with alpha lipoprotein mobility is present above and below density 
1.063. All precipitation lines were subsequently stained for lipid. 



FIGURE 7. 
IMMUNOELECTROPHORESIS ON AGAROSE OF PLASMA BEFORE AND AFTER 
PRECIPITATION WITH HEPARIN-MnCl2 FROM PATIENT W.W. WITH 
BILIARY CIRRHOSIS. 
All troughs contain combined anti-alpha and beta lipo¬ 
protein sera; R^A (48). Material with alpha mobility is 
present at densities above and below 1.063. All precipita¬ 
tion lines subsequently stained for lipid. 
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FIGURE 8. 
IMMUNODIFFUSION ON AGAROSE OF PLASMA AND DENSITY FRACTIONS < 1.063 
(FOLLOWING PRECIPITATION) FROM PATIENT W.W. WITH BILIARY CIRRHOSIS, 
AND NORMAL ALPHA LIPOPROTEIN FRACTION. 
The center well contains combined anti-alpha and beta lipoprotein 
sera, R^A (48). The wells on the left and right contain plasma 
fractions 1.006-1.063 from W.W. following precipitation with either 
Heparin-MnCl2 (Left) or specific anti-beta lipoprotein sera (Right), 
R7 (48). Complete identity with normal alpha lipoprotein, present 
in top well, was observed. The original plasma from W.W., in lower 
well, has both alpha and beta precipitation lines. All precipitation 
lines subsequently stained for lipid. 
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FIGURE 9. 
PAPER ELECTROPHORESIS OF PLASMA FROM NORMAL PATIENT AND M.J. 
WITH BILIARY CIRRHOSIS SECONDARY TO CHOLESTATIC HEPATITIS. 
On 9/15/66 with total cholesterol concentration of 2056 mgm7> 
no lipid staining material is present in normal alpha lipoprotein 
position, however, an unusual cathode-migrating band is present 
near the origin. On 12/12/66 as total cholesterol has decreased 
to 668 mgm% the alpha lipoprotein band is present in normal position 
but in abnormally increased amount. 
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FIGURE 10. 
IMMUNOELECTROPHORESIS ON AGAR OF PLASMA FROM PATIENT M.J. 
DURING ACUTE PHASE AND CONVALESCENCE FROM CHOLESTATIC 
HEPATITIS. 
The troughs contain combined anti-alpha and beta lipo¬ 
protein sera, R^A (48). On 9*15 no alpha lipoprotein pre¬ 
cipitin line is present, however, an unusual cathode- 
migrating precipitin line is present near the beta lipo¬ 
protein precipitin line. With return of cholesterol toward 
normal concentrations as seen in 12'12, alpha lipoprotein pre¬ 
cipitin line is present in normal position. All precipitation 
lines subsequently stained for lipid. 



FIGURE 11. 
IMMUNOELECTROPHORESIS ON AGAR OF LIPOPROTEIN FRACTION OF DENSITY 1.006- 
1.063 FROM M.J., 9/15/66. 
Troughs in slide Density < 1.063 contain combined anti-alpha and 
beta lipoprotein sera R^A (48). In A antisera have been absorbed 
with beta lipoprotein so they now react only with alpha lipoprotein. 
In B antisera have been absorbed with alpha lipoprotein so they 
now react only with beta lipoprotein. All precipitation lines sub¬ 
sequently stained for lipid. 
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FIGURE 12. 
IMMUNOELECTROPHORESIS ON AGAROSE OF PLASMA DENSITY 1.006 - 1.063 FRACTION 
FROM M.J., 9/15/66, BEFORE AND AFTER ETHER-ETHANOL DELIPIDATION. 
The troughs in slides Density < 1.063, and Density < 1.063 following 
ether-ethanol delipidation contain combined anti-alpha and beta 
lipoprotein sera, R^A (48). The slide Density < 1.063 following ether 
ethanol delipidation A, contains specific anti-alpha lipoprotein sera 
Rp (35), while B contains specific anti-beta lipoprotein sera, Ry (48) 
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